As the 2015 target date for achieving the Millennium Development Goals draws nearer, global and country-level discussions have kicked off to decide what will replace them.
Now that the voters in Colorado and Washington have approved marijuana legalization initiatives, attention has turned quickly to questions surrounding implementation—and in particular to speculation over how the federal government might react.
Mexico’s drug war has left more than 60,000 dead during this administration, according to the Federal Government. Current drug laws do little to combat the violence that is in fact threatening common citizens.
A group of Latin American leaders declared that the legalisation of marijuana in Washington and Colorado can have important implications for efforts to quash drug smuggling.
The Washington Office on Latin America (WOLA) seeks a Foundation Relations Manager to work in a three-person development team that is responsible for securing the organization’s $2 million and growing annual operating budget.
The International AIDS Society and the U.S. National Institute on Drug Abuse have announced a new round of their joint research fellowships to advance the scientific understanding of drug use and HIV.
IDHDP is seeking information to examine the barriers prevention good strategies to improve health and reduce the morbidity and mortality of hepatitis C among people who use drugs.
A range accessible, acceptable and sufficient quality (evidence based) options must be available that can help realise the child’s right to health and work in their best interests. What the Committee is clear about is that harm reduction has a vital role to play.
On 31 October 2012, the Eurasian Harm Reduction Network (EHRN) submitted a collective complaint on behalf of women who use drugs in Russia, Ukraine and Georgia to the UN Special Rapporteur on Violence against Women.
Opium poppy cultivation in Myanmar rose for the sixth consecutive year, despite a significant increase in Government eradication efforts, according to this UNODC report.
Responding to the emergence of new scientific evidence, WHO is in the process of developing a revised and consolidated set of guidelines related to the use of ARVs for HIV treatment and prevention, prioritising people who are most at risk.